Bexarotene

Links shared publicly online about this topic

In Mouse Model Bexarotene Quickly Reverses Alzheimer's Symptoms

medicalnewstoday.com — “Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, publisheView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 13, 2012 at 9:05 am By:

mnt_drugapprov MNT Drug Approvals Health News

In Mouse Model Bexarotene Quickly Reverses Alzheimer's Symptoms http://t.co/WdBsLELw #regulatory

3 months ago...

Eisai, Minophagen Pharma conclude bexarotene licensing agreement

pharmabiz.com — “Eisai, Minophagen Pharma conclude bexarotene licensing agreementView full resource at pharmabiz.com

  • View Related
  • Share

Most Recently Shared on April 3, 2012 at 1:16 pm By:

FiercePharma FiercePharma Health Site

Eisai signs over Targretin rights in Asia, ME and Eastern Europe to Minophagen, for up-front + milestones http://t.co/KqQFuAxl #pharma

2 months ago...

Bexarotene and erlotinib drugs effective in treating advanced lung cancer

news-medical.net — “Scientists have identified a drug combination, when used in advanced lung cancer patients, shows a survival advantage in patients who no longer respond to existing therapies.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 3, 2011 at 5:39 pm By:

LungCancer Lung Cancer OW OW Health

Bexarotene and erlotinib drugs effective in treating advanced lung cancer: Scientists have identified a drug com... http://bit.ly/mLUOlQ

12 months ago...

Bexarotene appears to help clear out excess plaque in Alzheimer's

news-medical.net — “"In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease," said Stacy Pagos Haller, President and CEO of the American Health Assistance Foundation (AHAF), a nonprofit that identifies and funds exceptionally high-impact research worldwide through its Alzheimer's Disease Research program.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 13, 2012 at 7:18 am By:

ALZHEIMERSreadAlzheimer's Reading Room is the number one source of life news for the entire Alzheimer's community. Our goal is to Educate, sometimes Entertain, and Empower Alzheimers caregivers and their families worldwide.


" /> Alzheimer's Reading Room Health Advocate

Bexarotene appears to help clear out excess plaque in Alzheimer's http://t.co/6YjiQQAp #alzheimers #news

3 months ago...

Bexarotene Confers No Survival Benefit for Mycosis Fungoides : Skin & Allergy News

skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, sView full resource at skinandallergynews.com

  • View Related
  • Share

Most Recently Shared on March 18, 2012 at 4:20 am By:

sknews Skin & Allergy News Health News

Bexarotene Confers No Survival Benefit for Mycosis Fungoides, according to poster presented at #aad12 http://t.co/C2nnA7Mv

2 months ago...

Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation For The Treatment Of Cutaneous T-Cell Lymphoma By The EC

medicalnewstoday.com — “Allos Therapeutics, Inc. (Nasdaq:ALTH) announced that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphomaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 20, 2010 at 12:04 pm By:

mnt_leukemia MNT Leukemia Health News

Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation For The Treatment Of Cutaneous T-Cell Ly... http://mnt.to/3F5V

2 years ago...

Cancer drug may help fight Alzheimer's - The Globe and Mail

theglobeandmail.com — “Bexarotene clears plaque from mouse brains in U.S. study, but researcher not sure it will work in human beingsView full resource at theglobeandmail.com

  • View Related
  • Share

Most Recently Shared on February 9, 2012 at 9:03 pm By:

AlzSociety Alzheimer Society Health Organization

Promising new #research that further expands our pool of knowledge and understanding of #Alzheimer’s disease. http://t.co/dwWmgnkX

4 months ago...

Thyroid Dysfunction from Antineoplastic Agents | Oral Cancer News

oralcancernews.org — “Thyroid Dysfunction from Antineoplastic Agents | Oral Cancer NewsView full resource at oralcancernews.org

  • View Related
  • Share

Most Recently Shared on October 19, 2011 at 6:29 pm By:

Alzheimer’s research is called ‘stunning’ | The Columbus Dispatch

dispatch.com — “A skin-cancer drug could offer hope for the millions of patients coping with the debilitating effects of Alzheimer’s disease. Scientists at Case Western Reserve University led a study of the drug bexarotene on mice and found that it helped wipe out a protein linked to Alzheimer’s.View full resource at dispatch.com

  • View Related
  • Share

Most Recently Shared on February 10, 2012 at 11:54 am By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • mnt_drugapprov

    MNT Drug Approvals

    The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • FiercePharma

    FiercePharma

    FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com

    View Profile

  • LungCancer

    Lung Cancer OW

    Organizing lung cancer resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390